SLC2A1 and melanoma: It was shown that hyperactivation of the JUP/AGR2/LYPD3 signaling axis contributes to the regulation of melanoma cell stemness and promotes glycolysis through a Glucose Transporter Type 1 (GLUT1)-dependent pathway.